Skip to main content

Peer Review reports

From: Raltitrexed enhanced antitumor effect of anlotinib in human esophageal squamous carcinoma cells on proliferation, invasiveness, and apoptosis

Original Submission
17 Oct 2022 Submitted Original manuscript
22 Nov 2022 Reviewed Reviewer Report
17 Jan 2023 Reviewed Reviewer Report
28 Jan 2023 Author responded Author comments - Bangwei Cao
Resubmission - Version 2
28 Jan 2023 Submitted Manuscript version 2
5 Feb 2023 Author responded Author comments - Bangwei Cao
Resubmission - Version 3
5 Feb 2023 Submitted Manuscript version 3
19 Feb 2023 Reviewed Reviewer Report
21 Feb 2023 Author responded Author comments - Bangwei Cao
Resubmission - Version 4
21 Feb 2023 Submitted Manuscript version 4
Publishing
28 Feb 2023 Editorially accepted
4 Mar 2023 Article published 10.1186/s12885-023-10691-y

You can find further information about peer review here.

Back to article page